Myelodysplastic Syndrome Podcasts Myelodysplastic Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Advances in understanding of MDS microenvironment
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Carmen Aanei elucidates recent advances in the understanding of the myelodysplastic... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Genetic basis of MDS
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Luca Malcovti discusses the genetic basis of myelodysplastic syndromes (MDS).<br /><br />Ea... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Experimental therapeutics in MPN: Where is the field going?
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Alessandro M. Vannucchi discusses the future of experimental therapeutics for the t... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Clonal evolution of MPN to accelerated or blastic phase: Therapeutic insights
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Srdan Verstovsek discusses therapeutic insights into the clonal evolution of myelop... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

My approach to MF management
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Claire Harrison outlines her approach to the management of myelofibrosis.<br /><br />Earn C... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

MF marrow morphology: Key takeaways from WHO 2016 diagnostic update
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Hans Michael Kvasnicka discsuses myelofibrosis marrow morphology and the key takeaw... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Experimental therapeutics in MDS New opportunities
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Jaroslav Cermak discusses new opportunities resulting from the utilization of exper... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Optimal use of lenalidomide as therapy for MDS
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Aristoteles Giagounidis discusses the optimal use of lanalidomide as therapy for my... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Iron chelation therapy for MDS
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Norbert Gattermann discusses iron chelation therapy for myelodysplastic syndromes (... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

My approach to MDS management
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Eva Hellstrm-Lindberg outlines her approach to the management of myelodysplastic s... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Hypocellular MDS vs. aplastic anemia - Diagnosis and therapy
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Austin G. Kulasekararaj discusses the difference between hypocellular MDS and aplas... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

My view on current and future use of JAK inhibitors for ET, PV, and MF
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Martin Griesshammer outlines his view on the current and future use of JAK inhibito... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Key Insights in MPN & MDS
In this discussion, recorded during the 2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 4-5, 2017 in Philadelphia, the Congress co-chairs highlight the key poi... Author: imedex Added: 08/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2017 Category: Cancer & Oncology Source Type: podcasts